Literature DB >> 15496273

Cytokines and stem cell mobilization for autologous and allogeneic transplantation.

Amanda F Cashen1, Daniel Link, Steven Devine, John DiPersio.   

Abstract

Mobilized peripheral blood has become the preferred source of stem cells for both autologous and allogeneic transplantation, and granulocyte colony-stimulating factor is the most widely used cytokine for mobilization. However, the mechanisms of cytokine-induced peripheral blood stem cell mobilization are not completely understood. Several recent studies suggest a model in which proteases released into the bone-marrow microenvironment during cytokine treatment play a critical role in mobilization. However, the finding that progenitor mobilization is normal in certain protease-deficient mice suggests that this model may be too simplistic. Here we review recent studies that advance our understanding of the biology of stem cell mobilization. We then discuss cytokines in current use and in development for mobilization of autologous and allogeneic peripheral blood stem cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15496273

Source DB:  PubMed          Journal:  Curr Hematol Rep        ISSN: 1540-3408


  9 in total

1.  NKT cell-dependent leukemia eradication following stem cell mobilization with potent G-CSF analogs.

Authors:  Edward S Morris; Kelli P A MacDonald; Vanessa Rowe; Tatjana Banovic; Rachel D Kuns; Alistair L J Don; Helen M Bofinger; Angela C Burman; Stuart D Olver; Norbert Kienzle; Steven A Porcelli; Daniel G Pellicci; Dale I Godfrey; Mark J Smyth; Geoffrey R Hill
Journal:  J Clin Invest       Date:  2005-10-13       Impact factor: 14.808

Review 2.  Granulocyte colony-stimulating factor: molecular mechanisms of action during steady state and 'emergency' hematopoiesis.

Authors:  Athanasia D Panopoulos; Stephanie S Watowich
Journal:  Cytokine       Date:  2008-04-08       Impact factor: 3.861

Review 3.  Hematopoietic stem cell mobilization: updated conceptual renditions.

Authors:  H Bonig; T Papayannopoulou
Journal:  Leukemia       Date:  2012-09-06       Impact factor: 11.528

4.  GM-CSF Enhances Mobilization of Bone Marrow Mesenchymal Stem Cells via a CXCR4-Medicated Mechanism.

Authors:  Jiyoung Kim; Na Kyeong Kim; So Ra Park; Byung Hyune Choi
Journal:  Tissue Eng Regen Med       Date:  2018-11-15       Impact factor: 4.169

5.  Clinical uses of GM-CSF, a critical appraisal and update.

Authors:  Martha Arellano; Sagar Lonial
Journal:  Biologics       Date:  2008-03

Review 6.  Regulatory systems in bone marrow for hematopoietic stem/progenitor cells mobilization and homing.

Authors:  P Alvarez; E Carrillo; C Vélez; F Hita-Contreras; A Martínez-Amat; F Rodríguez-Serrano; H Boulaiz; R Ortiz; C Melguizo; J Prados; A Aránega
Journal:  Biomed Res Int       Date:  2013-06-17       Impact factor: 3.411

7.  GM-CSF Down-Regulates TLR Expression via the Transcription Factor PU.1 in Human Monocytes.

Authors:  Kambis Sadeghi; Lukas Wisgrill; Isabelle Wessely; Susanne C Diesner; Simone Schüller; Celia Dürr; Armando Heinle; Monika Sachet; Arnold Pollak; Elisabeth Förster-Waldl; Andreas Spittler
Journal:  PLoS One       Date:  2016-10-03       Impact factor: 3.240

8.  Impaired Mobilization of Vascular Reparative Bone Marrow Cells in Streptozotocin-Induced Diabetes but not in Leptin Receptor-Deficient db/db Mice.

Authors:  Goutham Vasam; Shrinidh Joshi; Yagna P R Jarajapu
Journal:  Sci Rep       Date:  2016-05-18       Impact factor: 4.379

9.  Senescence chips for ultrahigh-throughput isolation and removal of senescent cells.

Authors:  Yuchao Chen; Pan Mao; Antoine M Snijders; Daojing Wang
Journal:  Aging Cell       Date:  2018-01-16       Impact factor: 9.304

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.